Healthcare

OUE Lippo Healthcare to expand network to Myanmar with $19.5m acquisition

It bought stakes in two joint venture companies with three hospitals, one medical centre and two clinics.

OUE Lippo Healthcare to expand network to Myanmar with $19.5m acquisition

It bought stakes in two joint venture companies with three hospitals, one medical centre and two clinics.

Medicine consumption in Australia to grow to AU$15.8b by 2022: Fitch

The country will remain one of the most attractive markets globally.

Asia to host to several healthcare megadeals in 2019

This includes pharmaceutical firm Takeda’s $58b acquisition of Ireland’s drug company Shire.

Asia to host to several healthcare megadeals in 2019

This includes pharmaceutical firm Takeda’s $58b acquisition of Ireland’s drug company Shire.

Australian health group Healius rejects $1.43b takeover proposal by Jangho Hong Kong

The Jangho Group holds 15.93% of the issued share capital of Healius.

Tax reliefs for insurance policies and new mothers may benefit Singapore's economy

Deductions could be subject to a cap which could be scaled according to age.

Healthcare boosted Singapore's capital markets in 2018

Four healthcare firms made their trading debut on SGX’s Catalist board.

OUE Lippo Healthcare to manage three Chinese medical facilities

It will expand its healthcare network into Shanghai, Chongqing and Nanjing.

Singapore's staggering healthcare costs may be pushing medical tourists away

Malaysia and Thailand offer more cost-competitive alternatives.

7 in 10 Singapore women worry about affordable healthcare after retirement

2 in 5 of them are either not checking how much they've put in for retirement or have no contributions at all.

Malaysia proposes 7.8% larger 2019 budget of US$6.9b for healthcare

It will allocate $8.4m of its healthcare budget to boost Malaysia’s image as a health tourism destination.

OUE Lippo Healthcare inks deal to develop high-end international hospital in Shenzhen

The hospital will have more than 200 beds serving the local community.

China's push for bulk medicine purchases a big no-no for pharmaceutical firms

Chinese drug stocks fell due to investor concerns on the average -52% drop in generic drug prices.

Singapore's war on diabetes will continue to spur drugmaker investment

Novo Nordisk and Abbott are amongst the most active players in the market.